Synthesis, characterization, cytotoxicity, and molecular docking studies of ampyrone-based transition metal complexes
- PDF / 745,412 Bytes
- 7 Pages / 595.276 x 790.866 pts Page_size
- 98 Downloads / 204 Views
Synthesis, characterization, cytotoxicity, and molecular docking studies of ampyrone‑based transition metal complexes Mohammad Azam1 · Saikh Mohammad Wabaidur1,6 · Mahboob Alam2 · Zahid Khan3 · Ibrahim O. Alanazi4 · Saud I. Al‑Resayes1 · Il Soo Moon5 · Rajendra6 Received: 3 June 2020 / Accepted: 20 August 2020 © Springer Nature Switzerland AG 2020
Abstract A novel series of mononuclear transition metal complexes, [Cu(L)Cl] 1, [Zn(L)Cl] 2, [Pd(L)Cl] 3, [Cd(L)I] 4, [Pt(L)Cl] 5, and [Hg(L)Cl] 6, was constructed from a pyrazole-derived Schiff ligand, HL, and characterized by physicochemical and spectroscopic methods. Fourier-transform infrared (FT-IR) spectral data showed the studied ligand to be tridentate and coordinated to the metal ions via ONO donor atoms, whereas powder X-ray diffraction (PXRD) analysis revealed the crystalline nature of all the complexes. The in vitro cytotoxicity of the studied ligand and its complexes were tested by the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay against the human colorectal cancer cell lines HCT116 and HT29. The results suggested that the HCT116 cell line is highly sensitive to complex 1 with a half-maximal inhibitory concentration ( IC50) of 45.6 μM, while both cell lines tolerated complexes 2 and 4 better in comparison with HL. In addition, complex 1 with significant anticancer activity was analyzed by molecular docking studies to explore its binding efficacy to the cyclin-dependent kinase 2 active site.
Introduction Cisplatin, a revolutionary drug in anticancer research, has been successfully applied in the treatment of various tumors, particularly ovarian, testicular, and neck cancers [1–3]. However, the use of cisplatin is limited because of its association with several side effects including nausea, hair loss, kidney toxicity, and nerve damage [4, 5]. These disadvantages linked to the use of cisplatin have motivated researchers to develop potential transition metal-based anticancer drugs Electronic supplementary material The online version of this article (https://doi.org/10.1007/s11243-020-00422-8) contains supplementary material, which is available to authorized users. * Mohammad Azam [email protected] * Mahboob Alam [email protected] * Rajendra [email protected] 1
2
Department of Chemistry, College of Science, King Saud University, P. O. Box 2455, Riyadh 11451, Kingdom of Saudi Arabia Division of Chemistry and Biotechnology, Dongguk University, 123 Dongdae‑ro, Gyeongju, Republic of Korea
with reduced side effects and wide-spectrum action against curable cancers [6–8]. Schiff bases, which are versatile organic blockers, are considered to be the most “privileged ligands” and have been widely used due to their preparative accessibility, structural diversity, and solubility in most common organic solvents [9, 10]. Furthermore, Schiff base ligands coordinate to various metal ions due to their strong chelating properties and stabilize them in various oxidation states [11]. Over the past sev
Data Loading...
